Biopharmaceuticals
Large-scale Industrial Base
The company has built a biopharmaceutical production base compliant with international GMP standards, focusing on the industrialized production of insulin series biological products, with full-chain independent production capabilities from active pharmaceutical ingredient (API) to drug product.
Full-process Quality Control
Strictly adhering to international quality management system standards and relying on proprietary core technologies, the company achieves full-process quality control and production traceability, ensuring product consistency and safety.
Efficient and Stable Supply Chain Assurance
Possessing both standardized and large-scale production capabilities, with flexible supply chain management from R&D to commercialization, the company can flexibly allocate production capacity to efficiently ensure a continuous supply for Chinese and international markets.
